Articles by Tomer Ze'ev

FDA approves Rybrevant for advanced lung cancer

The FDA approved the drug amivantamab-vmjw in combination with standard chemotherapy for the treatment of certain adults with non-small cell lung cancer, according to a press release by Johnson & Johnson. The indication applies to adults with locally advanced or metastatic…



Is human lifespan limited by a single molecule?

A paper recently published by Dr. Ádám Sturm and Dr. Tibor Vellai from Eötvös Loránd University uncovers the critical role of mitochondrial DNA, as well as the different ways in which it can be modified and how these modifications impact…